FDA approves Abbott TriClip TEER system
Abbott (NYSE: ABT) announced that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system.
Stay updated with breaking news from Sam Eiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE: ABT) announced that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system.
Analysts called the move "a major twist ... likely to be welcomed by shareholders" two years after Masimo's controversial Sound United deal.
Masimo shares fell slightly despite fourth-quarter results that came in ahead of the consensus forecast.
Insulet (Nasdaq:PODD) announced today that it began a limited market release of the Omnipod 5 with the Dexcom G7.
IRhythm Technologies (Nasdaq: IRTC) shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast.